Skip to main content
XAIR
NASDAQ Industrial Applications And Services

Beyond Air Reports 107% FY26 Revenue Growth, Projects >110% CY27 Growth Amidst Nasdaq Compliance Efforts

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.481
Mkt Cap
$6.283M
52W Low
$0.335
52W High
$4.78
52W Position info
44% above low
Off High info
90% below high
Rel. Volume info
3.6× avg
Market data snapshot near publication time

XAIR sits 44% above its 52-week low of $0.335 on elevated volume (3.6× avg).

Summary

Beyond Air reported strong fiscal year 2026 revenue growth and issued optimistic guidance for 2027, projecting over 110% growth, which is critical as the company faces a Nasdaq delisting deadline and a going concern warning.


Key Events · Earnings and Guidance · XAIR

  • Strong Fiscal Year 2026 Revenue Growth

    Beyond Air reported a 107% year-over-year increase in revenue to $7.7 million for the fiscal year ended March 31, 2026, with Q4 revenue up 66% to $1.9 million.

  • Optimistic Revenue Guidance for 2026 and 2027

    The company projects $8 million in revenue for calendar year 2026 (15% growth) and $16-$18 million for calendar year 2027, representing over 110% year-over-year growth at the midpoint.

  • Potential Market Expansion with Second-Generation Product

    Awaiting FDA approval for its second-generation LungFit PH system, which, if approved with a broader label, could increase the total addressable U.S. market by 4x to approximately $400 million and worldwide to over $1 billion.

  • Fiscal Year-End Change Approved

    The Board of Directors approved changing the company's fiscal year-end from March 31 to December 31, effective December 31, 2026, with a nine-month transition period.


Analysis · XAIR · Industrial Applications And Services

Beyond Air reported strong fiscal year 2026 revenue growth of 107% to $7.7 million, with Q4 revenue up 66%. More significantly, the company provided revenue guidance of $8 million for calendar year 2026 (15% growth) and $16-$18 million for calendar year 2027, representing over 110% year-over-year growth. This optimistic outlook is contingent on the FDA approval of its second-generation LungFit PH system, which could expand the total addressable U.S. market by 4x to $400 million and worldwide to over $1 billion. This positive forward-looking guidance is crucial for the company, which recently received a Nasdaq delisting notice and a going concern warning in its 10-K filed on the same day. The Board also approved a change in the fiscal year-end from March 31 to December 31, effective December 31, 2026, to align with calendar year reporting.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XAIR was trading at $0.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.3M. The 52-week trading range was $0.33 to $4.78. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XAIR - Latest Insights

XAIR
Nov 12, 2026, 9:17 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $1.94 info
Change: Low Volume info
Market Cap: $3.239M info
XAIR
Nov 11, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.18
Real-time Price: $1.94 info
Change: Low Volume info
Market Cap: $3.239M info
XAIR
Oct 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.45
Real-time Price: $1.94 info
Change: Low Volume info
Market Cap: $3.239M info
XAIR
Aug 31, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.73
Real-time Price: $1.94 info
Change: Low Volume info
Market Cap: $3.239M info
XAIR
Aug 25, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.78
Real-time Price: $1.94 info
Change: Low Volume info
Market Cap: $3.239M info